---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-066407"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T22:02:36.761119+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Plus Therapeutics CEO presents at JonesResearch webcast; no material new details in filing

## Summary
- CEO Marc Hedrick presented at a JonesResearch webcast on March 12, 2024.
- Presentation slides filed as Exhibit 99.1 but no specific financial or operational data extracted from filing text.
- Slides to be used in upcoming investor meetings as part of Regulation FD disclosure.

## SEC filing metadata
- accession: 0001193125-24-066407
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312524066407/0001193125-24-066407-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312524066407/d804804d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-066407
- JSON: https://secwatch.observer/filing/0001193125-24-066407.json
- Plain text: https://secwatch.observer/filing/0001193125-24-066407.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.